Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

California shows the way for biosecurity in commercial gene synthesis

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    AB-1966 Gene Synthesis Providers. Edn. 2019–2020 Regular Session (2020).

  2. 2.

    US National Academies of Sciences, Engineering and Medicine. Biodefense in the Age of Synthetic Biology (National Academies Press, 2018).

  3. 3.

    Department of Health and Human Services. Fed. Regist. 75, 62820–62832 (2010).

    Google Scholar 

  4. 4.

    Carter, S. R. & Friedman, R. M. DNA Synthesis and Biosecurity: Lessons Learned and Options for the Future (J. Craig Venter Institute, 2015).

  5. 5.

    Kobokovich, A., West, R., Montague, M., Inglesby, T. & Gronvall, G. K. Health Secur. 17, 419–429 (2019).

    Article  Google Scholar 

  6. 6.

    Bergin, J. Synthetic Biology: Global Markets (BCC Research, 2018).

Download references

Author information



Corresponding author

Correspondence to Gigi Kwik Gronvall.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

West, R., Gronvall, G.K. California shows the way for biosecurity in commercial gene synthesis. Nat Biotechnol 38, 1021 (2020).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing